Our discovery that plasmids containing the Friedreich's ataxia (FRDA) expanded GAA⅐TTC sequence, which forms sticky DNA, are prone to form dimers compared with monomers in vivo is the basis of an intracellular assay in Escherichia coli for this unusual DNA conformation. Sticky DNA is a single long GAA⅐GAA⅐TTC triplex formed in plasmids harboring a pair of long GAA⅐TTC repeat tracts in the direct repeat orientation. This requirement is fulfilled by either plasmid dimers of DNAs with a single trinucleotide repeat sequence tract or by monomeric DNAs containing a pair of direct repeat GAA⅐TTC sequences. DNAs harboring a single GAA⅐TTC repeat are unable to form this type of triplex conformation. An excellent correlation was observed between the ability of a plasmid to adopt the sticky triplex conformation as assayed in vitro and its propensity to form plasmid dimers relative to monomers in vivo. The variables measured that strongly influenced these measurements are as follows: length of the GAA⅐TTC insert; the extent of periodic interruptions within the repeat sequence; the orientation of the repeat inserts; and the in vivo negative supercoil density. Nitrogen mustard cross-linking studies on a family of GAA⅐TTC-containing plasmids showed the presence of sticky DNA in vivo and, thus, serves as an important bridge between the in vitro and in vivo determinations. Biochemical genetic studies on FRDA containing DNAs grown in recA or nucleotide excision repair or ruv-deficient cells showed that the in vivo properties of sticky DNA play an important role in the monomer-dimer-sticky DNA intracellular interconversions. Thus, the sticky DNA triplex exists and functions in living cells, strengthening the likelihood of its role in the etiology of FRDA.Friedreich's ataxia (FRDA), 1 an autosomal recessive neurodegenerative disease, is the most common inherited ataxia (1). The clinical and molecular biology features of FRDA have been reviewed (1-5). The FRDA gene (X25) contains seven exons and encodes a 210-amino acid protein named frataxin (1). Ninety eight percent of FRDA patients have an expanded GAA⅐TTC repeat in the first intron of the frataxin gene, and 2% have point mutations. FRDA is a typical triplet repeat disease (6) because an expansion of the repeat is found in patients; normal alleles have 6 -34 repeats of GAA⅐TTC, but the FRDA patient alleles have 66 -1700 repeats (1-3, 6). Individuals with longer GAA⅐TTC repeats (reviewed in Ref. 1) have an earlier age of onset and more severe disease manifestations.FRDA is a loss of function disease because patients with two expanded alleles have reduced levels of frataxin. Also, a reduction in the amount of the frataxin protein, a mitochondrial protein involved in iron metabolism, is because of a diminution in the abundance of the frataxin mRNA (1). This inhibition of transcription is caused by the capacity of long GAA⅐TTC repeats to form triplexes (three-stranded DNA structures) that are known to effect this inhibition (5,(7)(8)(9)(10)(11)(12). FRDA is the only triplet repeat di...